PortViewPortView
SMRI logo

Bushido Capital US Equity (SMRI) ETF Holdings & Analysis

ETFOther

$46.74+0.12%
1-year price historyRange $34.14 – $49.28
52-week range$46.74
$34.10$50.48

Track SMRI in your portfolio for free · Portfolio tracker

What SMRI does

Operating as an actively managed exchange-traded fund (ETF), this fund endeavors to achieve its financial objectives primarily through investing in U.S.-listed common equities. Customarily, at least 80% of its combined assets—comprising both net assets and any borrowed funds used for investment—are allocated to these securities.

Fund profile

Category
Other
AUM
$700.79M
Holdings
10
52-week high
$50.48
52-week low
$34.10

Top holdings

Top 1023%
HoldingWeight
Accenture PLC2.54%
United Therapeutics Corp2.37%
ConocoPhillips2.27%
Intuit Inc2.25%
Cognizant Technology Solutions Corp2.24%
EOG Resources Inc2.24%
Autodesk Inc2.22%
Leidos Holdings Inc2.20%
ExxonMobil Holdings Corp2.19%
Royalty Pharma PLC2.18%

Geographic allocation

United States95.57%
Ireland4.44%

PortView Portfolio Insights

PortView analyzes how SMRI fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SMRI in PortView →

Related securities

Related stocks

Frequently asked questions

What does SMRI track?
SMRI is the Bushido Capital US Equity ETF, a Other ETF.
What is the expense ratio of SMRI?
Expense ratio data for SMRI is shown on the page when available from our data provider.
What are the largest holdings in SMRI?
Top holdings include ACN, UTHR, COP, INTU, CTSH.
How can PortView analyze SMRI overlap with other ETFs?
PortView computes the holdings overlap between SMRI and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.